Lexicon Pharmaceuticals Inc Capital Reinvestment Ratio
Lexicon Pharmaceuticals Inc capital reinvestment ratio. Lexicon Pharmaceuticals Inc (LXRX) has a Capital Reinvestment Ratio of 0.00x as of September 2019, meaning it reinvests 0% of its operating cash flow ($190.70 Million) in capital expenditures ($70.00K). Check LXRX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Lexicon Pharmaceuticals Inc (2005–2019)
Capital reinvestment ratio of Lexicon Pharmaceuticals Inc from 2005 to 2019. This chart tracks Lexicon Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Lexicon Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Lexicon Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2005–2019)
Lexicon Pharmaceuticals Inc capital reinvestment ratio by year from 2005 to 2019. For the full cash flow conversion analysis, see Lexicon Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $113.81 Million | $70.00K | ▼ -87.5% |
| 2015 | 0.00x | $184.78 Million | $910.00K | ▼ -99.0% |
| 2005 | 0.48x | $23.44 Million | $11.28 Million | — |